Effect of hepatic impairment on the pharmacokinetics (PK) of rosiglitazone (RSG)

A. K. Miller, A. L. Inglis, K. Thompson, C. C. Davie, S. Schenker, R. Blum, D. Jorkasky, M. I. Freed

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Effect of hepatic impairment on the pharmacokinetics (PK) of rosiglitazone (RSG)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions